These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 19038750)
21. Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting. Hahr AJ; Molitch ME Dis Mon; 2010 Mar; 56(3):148-62. PubMed ID: 20189500 [TBL] [Abstract][Full Text] [Related]
22. Comparison of preference for NovoPen(®) 4 with previous insulin pen treatments after 12 weeks in adult patients with type 1 and type 2 diabetes: a multicenter observational study. Israël-Bultman H; Hyllested-Winge J; Kolaczynski M; Steindorf J; Garon J Clin Ther; 2011 Mar; 33(3):346-57. PubMed ID: 21600387 [TBL] [Abstract][Full Text] [Related]
24. [Practical points in the use of insulin and oral hypoglycemic agents]. Nakayama H Hokkaido Igaku Zasshi; 1989 Jul; 64(4):387-90. PubMed ID: 2684832 [No Abstract] [Full Text] [Related]
25. [Insulin, glibenclamide plus acarbose in diabetes mellitus?]. Hauner H Dtsch Med Wochenschr; 1995 Nov; 120(46):1605. PubMed ID: 7588044 [No Abstract] [Full Text] [Related]
27. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus. Pham DQ; Cohen H; Chu V J Clin Pharmacol; 2007 Jul; 47(7):890-903. PubMed ID: 17585117 [TBL] [Abstract][Full Text] [Related]
28. The use of bolus insulin and advancing insulin therapy in type 2 diabetes. Karl DM Curr Diab Rep; 2004 Oct; 4(5):352-7. PubMed ID: 15461900 [TBL] [Abstract][Full Text] [Related]
29. Intensive insulin therapy in patients with type 2 diabetes. Bering B; Devendra D Lancet; 2008 Aug; 372(9640):716-7; author reply 717-8. PubMed ID: 18761218 [No Abstract] [Full Text] [Related]
30. Understanding insulin in day-to-day practice. Poole R; Krentz AJ Practitioner; 2001 Apr; 245(1621):324-6, 330, 332 passim. PubMed ID: 11332006 [No Abstract] [Full Text] [Related]
31. [Escaping oral hypoglycemic agents in type 2 diabetes: importance and limitations of transitory optimized insulin therapy]. Leutenegger M; Bertin E; Grulet H Diabetes Metab; 1998 Feb; 24(1):80-4. PubMed ID: 9534015 [No Abstract] [Full Text] [Related]
32. Use of continuous subcutaneous insulin infusion in cystic fibrosis patients with cystic fibrosis-related diabetes awaiting transplantation. Reali MF; Festini F; Neri AS; Taccetti G; Repetto T; Chiarelli F; Toni S J Cyst Fibros; 2006 Jan; 5(1):67-8. PubMed ID: 16233992 [No Abstract] [Full Text] [Related]
33. New concepts in diabetes: how multihormonal regulation can improve glycemic control. Blonde L; Baker DE; Davis SN; Ratner RE J Manag Care Pharm; 2004 Dec; 10(6 Suppl B):S3-8; quiz S9, S11-2. PubMed ID: 23570175 [TBL] [Abstract][Full Text] [Related]